Metraipolis › archive › dc_02dd938fb7cb

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41019979
DOI
10.20517/cdr.2025.133
License (as archived)
solo-consultazione
Archived
2026-11-10T01:44:40.147Z
SHA-256 of the archived text
36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434
Stable URL of this page
https://metraipolis.com/documento/dc_02dd938fb7cb

How to cite

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979 — Europe PMC (en), https://europepmc.org/article/MED/41019979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02dd938fb7cb (Metraipolis archive dc_02dd938fb7cb, sha256 36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434)
BibTeX
@misc{dc02dd938fb7cb,
  title = {Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019979},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02dd938fb7cb; sha256 36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019979. Agents can read the archived copy with the MCP tool read_document.